Coronavirus COVID-19 Updates: uc.edu/publichealth
University of Cincinnati Brain Tumor Center members specialize in discovery and translational research in disciplines including epigenetics, metabolomics, pharmaceutical sciences, cancer etiology and more.
Visit the webpages of BTC Research Investigators to learn about our research programs.
Customized tumor modeling platform
Cancer signaling & metabolism
Brain development and glioblastoma
Pharmacokinetics & Pharmacodynamics
Repurposed therapeutics & Glioblastoma
IDH1 mutant glioma
Transcriptional control Olig2
Pediatric brain tumors
Mouse models and preclinical testing
Focused ultrasound drug delivery
Brain metastases & Phospholipid targeting
Therapeutic discovery & Novel imaging modality
Metastatic tumors & Glioblastoma
Nucleotide metabolism & Repurposed therapeutics
Neuro-oncology & Clinical trials
Brain metastasis – melanoma & lung Glioblastoma Medulloblastoma
Drug delivery nanomaterials
Breast cancer brain metastasis & Autophagy & Bioenergy
The Brain Tumor Center is directed by Dr. Mario Zuccarello MD, Department of Neurosurgery. Dr. Soma Sengupta MD PhD is the BTC Associate Director for Clinical Trials, and Dr. David Plas is the BTC Associate Director for Research.
Membership is available to all investigators with an interest in primary or metastatic brain tumors in the clinical and research communities at University of Cincinnati, Cincinnati Children’s Hospital Medical Center, and the Cincinnati VA Medical
To make an appointment or contact the Brain Tumor Center care team, visit the UC Brain Tumor Center at UCHealth.